FDA Commissioner Scott Gottlieb reiterated the call for new funding mechanisms to combat antimicrobial resistance during remarks made at a Pew Charitable Trusts meeting Friday. Gottlieb also revealed FDA's 2019 strategic plan to address AMR, noting it builds on the agency's past efforts and will bring together the agency's centers.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,